M2 macrophages are known to promote tissue repair, ECM deposition, angiogenesis, and lesion maintenance, and their inhibition reduces the inflammation that sustains disease progression (Guan et al., 2025
The pharmacist's bottom line Compounded semaglutide occupies a legitimate but imperfect space in a healthcare system where brand-name GLP-1 medications remain financially inaccessible for many patients who would genuinely benefit from them
Publication Details Paper Title: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation | Authors: Huilin Tang, Bingyu Zhang, Yiwen Lu, Dazheng Zhang, Ruishan Liu, Yuan Lu, George Cotsarelis, David A
Microdosing makes it easier for them to stick with treatment while feeling less discomfort
Over half of corporate and multiemployer/public plans cover GLP-1s for diabetes only, while roughly one-third in each group extend coverage to both diabetes and weight loss